Open AccessMetronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
Author(s) -
Rui Geng,
Gang Wang,
Lei Qiu,
Bing Liu,
Fan Yang,
Jingyu Zhang,
Yi Miao
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000023719
Subject(s) - medicine , capecitabine , hazard ratio , clinical endpoint , colorectal cancer , adverse effect , neutropenia , maintenance therapy , oncology , confidence interval , randomized controlled trial , randomization , induction chemotherapy , chemotherapy , surgery , cancer